Supreme Speciality Hospitals Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 17-11-2024
- Paid Up Capital ₹ 7.00 M
as on 17-11-2024
- Company Age 7 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.02 Cr
as on 17-11-2024
- Revenue 40.65%
(FY 2023)
- Profit -26.15%
(FY 2023)
- Ebitda 30.56%
(FY 2023)
- Net Worth 165.22%
(FY 2023)
- Total Assets 20.00%
(FY 2023)
About Supreme Speciality Hospitals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 7.00 M.
The company currently has active open charges totaling ₹3.02 Cr.
Kumar Rajeshkumar and Vendamirtham Saravanan serve as directors at the Company.
- CIN/LLPIN
U85100TN2017PTC117162
- Company No.
117162
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Jun 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Kanchipuram, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Supreme Speciality Hospitals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kumar Rajeshkumar  | Director | 20-Jun-2017 | Current |
| Vendamirtham Saravanan | Director | 20-Jun-2017 | Current |
Financial Performance of Supreme Speciality Hospitals.
Supreme Speciality Hospitals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 40.65% increase. The company also saw a substantial fall in profitability, with a 26.15% decrease in profit. The company's net worth Soared by an impressive increase of 165.22%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Supreme Speciality Hospitals?
In 2023, Supreme Speciality Hospitals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
S3 Medical Enterprises Private LimitedActive 1 year 6 daysKumar Rajeshkumar and Vendamirtham Saravanan are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
City Union Bank Limited Creation Date: 10 Jun 2020 | ₹4.70 M | Open |
City Union Bank Limited Creation Date: 22 Dec 2017 | ₹2.55 Cr | Open |
How Many Employees Work at Supreme Speciality Hospitals?
Supreme Speciality Hospitals has a workforce of 82 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Supreme Speciality Hospitals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Supreme Speciality Hospitals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
